179 related articles for article (PubMed ID: 15138166)
1. Synergistic effects on erythropoiesis, thrombopoiesis, and stem cell competitiveness in mice deficient in thrombopoietin and steel factor receptors.
Antonchuk J; Hyland CD; Hilton DJ; Alexander WS
Blood; 2004 Sep; 104(5):1306-13. PubMed ID: 15138166
[TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin promotes mixed lineage and megakaryocytic colony-forming cell growth but inhibits primitive and definitive erythropoiesis in cells isolated from early murine yolk sacs.
Xie X; Chan RJ; Johnson SA; Starr M; McCarthy J; Kapur R; Yoder MC
Blood; 2003 Feb; 101(4):1329-35. PubMed ID: 12393382
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness.
Bradley HL; Couldrey C; Bunting KD
Blood; 2004 Apr; 103(8):2965-72. PubMed ID: 15070672
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin.
Kimura S; Roberts AW; Metcalf D; Alexander WS
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1195-200. PubMed ID: 9448308
[TBL] [Abstract][Full Text] [Related]
6. Thrombocytopenia in c-mpl-deficient mice.
Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
[TBL] [Abstract][Full Text] [Related]
7. Ectopic overexpression of c-mpl by retroviral-mediated gene transfer suppressed megakaryopoiesis but enhanced erythropoiesis in mice.
Yan XQ; Lacey DL; Saris C; Mu S; Hill D; Hawley RG; Fletcher FA
Exp Hematol; 1999 Sep; 27(9):1409-17. PubMed ID: 10480432
[TBL] [Abstract][Full Text] [Related]
8. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis.
Avecilla ST; Hattori K; Heissig B; Tejada R; Liao F; Shido K; Jin DK; Dias S; Zhang F; Hartman TE; Hackett NR; Crystal RG; Witte L; Hicklin DJ; Bohlen P; Eaton D; Lyden D; de Sauvage F; Rafii S
Nat Med; 2004 Jan; 10(1):64-71. PubMed ID: 14702636
[TBL] [Abstract][Full Text] [Related]
9. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.
Muraoka K; Ishii E; Tsuji K; Yamamoto S; Yamaguchi H; Hara T; Koga H; Nakahata T; Miyazaki S
Br J Haematol; 1997 Feb; 96(2):287-92. PubMed ID: 9029014
[TBL] [Abstract][Full Text] [Related]
10. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl.
Alexander WS; Roberts AW; Nicola NA; Li R; Metcalf D
Blood; 1996 Mar; 87(6):2162-70. PubMed ID: 8630375
[TBL] [Abstract][Full Text] [Related]
11. Role of c-mpl in early hematopoiesis.
Solar GP; Kerr WG; Zeigler FC; Hess D; Donahue C; de Sauvage FJ; Eaton DL
Blood; 1998 Jul; 92(1):4-10. PubMed ID: 9639492
[TBL] [Abstract][Full Text] [Related]
12. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.
Geddis AE; Fox NE; Kaushansky K
Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394
[TBL] [Abstract][Full Text] [Related]
13. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor.
Gainsford T; Nandurkar H; Metcalf D; Robb L; Begley CG; Alexander WS
Blood; 2000 Jan; 95(2):528-34. PubMed ID: 10627458
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous signalling through c-mpl, c-kit and CXCR4 enhances the proliferation and differentiation of human megakaryocyte progenitors: possible roles of the PI3-K, PKC and MAPK pathways.
Minamiguchi H; Kimura T; Urata Y; Miyazaki H; Bamba T; Abe T; Sonoda Y
Br J Haematol; 2001 Oct; 115(1):175-85. PubMed ID: 11722431
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with Kit(Wv) Mutations.
Yurino A; Takenaka K; Yamauchi T; Nunomura T; Uehara Y; Jinnouchi F; Miyawaki K; Kikushige Y; Kato K; Miyamoto T; Iwasaki H; Kunisaki Y; Akashi K
Stem Cell Reports; 2016 Sep; 7(3):425-438. PubMed ID: 27499200
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin: accumulating evidence for an important biological effect on the hematopoietic stem cell.
Kaushansky K
Ann N Y Acad Sci; 2003 May; 996():39-43. PubMed ID: 12799280
[TBL] [Abstract][Full Text] [Related]
17. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
[TBL] [Abstract][Full Text] [Related]
18. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy.
Kaushansky K; Broudy VC; Grossmann A; Humes J; Lin N; Ren HP; Bailey MC; Papayannopoulou T; Forstrom JW; Sprugel KH
J Clin Invest; 1995 Sep; 96(3):1683-7. PubMed ID: 7657840
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietin (TPO) induces thrombocytic colony formation of kidney cells synergistically with kit ligand A and a non-secretory TPO variant exists in common carp.
Katakura F; Sugie Y; Hayashi K; Nishiya K; Miyamae J; Okano M; Nakanishi T; Moritomo T
Dev Comp Immunol; 2018 Jul; 84():327-336. PubMed ID: 29522790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
